- Home
- MNKD vs OLMA Comparison
MNKD vs OLMA Comparison
Compare MNKD & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNKD | OLMA |
|---|---|---|
| Founded | 1991 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MNKD | OLMA |
|---|---|---|
| Price | $2.78 | $14.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $8.64 | ★ $41.13 |
| AVG Volume (30 Days) | ★ 6.6M | 1.5M |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $348,966,000.00 | N/A |
| Revenue This Year | $33.40 | N/A |
| Revenue Next Year | $16.48 | N/A |
| P/E Ratio | $140.75 | ★ N/A |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $2.52 | $2.86 |
| 52 Week High | $6.51 | $36.26 |
Technical Indicators
Market Signals| Indicator | MNKD | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 23.75 | 20.04 |
| Support Level | N/A | $4.35 |
| Resistance Level | $6.08 | $27.38 |
| Average True Range (ATR) | 0.37 | 1.35 |
| MACD | -0.05 | -0.94 |
| Stochastic Oscillator | 7.79 | 3.20 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.